Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Digoxin in Adults With Non-alcoholic Steatohepatitis
NCT04216693Phase 2Withdrawn
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jun 2020
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of digoxin in Nonalcoholic steatohepatitis (NASH), sponsored by Nanjing Drum-Tower Hospital. Planned start Jun 2020; status: withdrawn.
02
Drugs
digoxin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04216693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04216693.